Government Affairs
Refine Search
Pharmaceutical
Indian drug companies have a new ally. The UAE government is all set to provide incentives, including financial contributions, and will help create a full ecosystem to support Indian pharmaceutical companies having strong research and development facilities, reports The Pharma Letter’s India correspondent. 2 November 2020
Generics
Even as the Madras High court raises concern over India’s over-dependence on Chinese pharma ingredients, the Indian government has expanded and amended the Production-Linked Incentive (PLI) scheme aimed at strengthening India's indigenous production of active pharmaceutical ingredients (APIs). 30 October 2020
Biotechnology
Eli Lilly has announced an initial agreement with the US government to supply 300,000 vials of bamlanivimab 700mg for $375 million. 28 October 2020
Pharmaceutical
For two years from January 1, 2021, once the transition period after Brexit has come to an end, the UK will adopt decisions taken by the European Commission (EC) on the approval of new medicines in the community marketing authorization procedure. 27 October 2020
Pharmaceutical
In Russia, 10 industry associations of the pharmaceutical market have turn to the Head of Government, as the situation with medicine labelling is becoming extremely critical for the supply of drugs, notes a posting on the website of the Association of International Pharmaceutical Manufacturers (AIPM). 26 October 2020
Pharmaceutical
PharmaLex, a provider of specialized services for the pharma, biotech and health industries, has drafted a whitepaper focusing on the challenges Brexit poses to the pharmaceutical industry and what actions are required now to ensure companies remain compliant once the transition phase ends. (https://www.pharmalex.com/. An outline of this follows. 23 October 2020
Pharmaceutical
Reducing patient healthcare costs is imperative, write Matthew Majewski and Andrew Parece, vice presidents of Charles River Associates, in a Special Report. 21 October 2020
Pharmaceutical
The pharmaceutical industry and others involved in the supply of medical items in the UK want the Prime Minister to get a trade deal with the European Union. 16 October 2020
Generics
India's Chemicals and Fertilizers Minister D V Sadananda Gowda has invited Latin American and Caribbean countries to invest in the Indian pharma sector, stating that it could grow to become a $65 billion industry by 2024. With the government recently launching schemes for the development of drug parks across the country, the Minister said India could well replace China as the world's factory, reports The Pharma Letter’s India correspondent. 16 October 2020
Pharmaceutical
India’s regulatory agency the National Pharmaceutical Pricing Authority (NPPA) has detected and issued about 162 demand notices against pharmaceutical companies in India for overcharging consumers with regards to the sale of anti-diabetic and cardiac care formulations whose prices were fixed under Para 19 of the Drugs (Prices Control) Order, 2013. 16 October 2020
Pharmaceutical
The All-Russian Union of Patients (VSP) has called on the national government to create conditions for distance selling of drugs in the domestic market and to begin their public procurements directly from manufacturers, instead of distributors. 13 October 2020
Biotechnology
The US Department of Health and Human Services (HHS) and Department of Defense (DoD) on Friday announced an agreement with UK pharma major AstraZeneca for late-stage development and large-scale manufacturing of the company's COVID-19 investigational product AZD7442. 10 October 2020
Biotechnology
Subsequent to discussions with regulatory authorities, Regeneron Pharmaceuticals says it has submitted a request to the US Food and Drug Administration for an Emergency Use Authorization (EUA) for its REGN-COV2 investigational antibody combination for the treatment of COVID-19. 8 October 2020
Pharmaceutical
Executives from Amgen, Novartis and Mallinckrodt were the second group to spend an uncomfortable day in front of the US House Committee on Oversight and Reform. 5 October 2020
Biotechnology
Speaking at the Financial Times’ US Pharma and Biotech Conference yesterday, Moderna Therapeutics’ chief executive Stéphane Bancel stated that the company will not be able to apply for emergency use authorization (EUA) in the USA for its COVID-19 vaccine candidate mRNA-1273 before November 25 at the earliest, reflecting the minimum amount of time needed to accumulate enough safety data. 1 October 2020
Pharmaceutical
The US House Committee on Oversight and Reform is beginning to release a series of new staff reports detailing the findings of its sweeping investigation into the skyrocketing prices of prescription drugs. 1 October 2020
Pharmaceutical
The United Nations (UN) has welcomed a series of recent pledges made by governments and other donors to help the wider international fight to bolster access to lifesaving tests, treatments and vaccines to end COVID-19. 1 October 2020
Pharmaceutical
The Australian government today announced a A$1.3 billion ($915 million) Modern Manufacturing Initiative (MMI) and the National Manufacturing Priorities. 1 October 2020
Pharmaceutical
Trade groups representing the pharmaceutical industry in the UK and the EU have come together to call on authorities to prioritize medicines in ongoing trade talks. 28 September 2020
Biotechnology
Following a review meeting in July 2020, the NHS England Clinical Priorities Advisory Group (CPAG) has provided a positive recommendation for the routine commissioning of Veyvondi (vonicog alfa), the first and only recombinant von Willebrand factor (VWF) treatment for adults with von Willebrand disease (VWD), 25 September 2020
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze